A cohort of 137 human brain tissue samples from 109 patients was established, consisting of 49 IDH-mutant glioma samples, 74 IDH-wildtype glioma samples, and 14 normal brain tissue samples (Figure 4A). The gene discussed is IDH2; the disease is central nervous system cancer.